Accordingly, Galc silencing results in significant inhibition of the tumorigenic and metastatic activity of Braf wildtype murine melanoma B16-F10 cells that showed alterations in their sphingolipid profile, characterized by an increase in the intracellular levels of the oncosuppressor sphingolipid ceramide. This evidence concerns the gene GALC and melanoma.